Article
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Oncotarget - 29 Nov 2016
Paschall Amy V, Yang Dafeng, Lu Chunwan, Redd Priscilla S, Choi Jeong-Hyeon, Heaton Christopher M, Lee Jeffrey R, Nayak-Kapoor Asha, Liu Kebin
Abstract excerpt
The chemotherapeutic agent 5-Fluorouracil (5-FU) is the most commonly used drug for patients with advanced colon cancer. However, development of resistance to 5-FU is inevitable in almost all patients. The mechanism by which colon cancer develops 5-FU resistance is still unclear. One recently proposed theory is that cancer stem-like cells underlie colon cancer 5-FU resistance, but the phenotypes of 5-FU-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
